Ubs Group Ag Daxor Corp Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$7.0 - $8.5 $15,911 - $19,320
-2,273 Reduced 87.46%
326 $2,000
Q4 2024

Feb 14, 2025
BUY
$7.63 - $9.89 $10,399 - $13,480
1,363 Added 110.28%
2,599 $20,000
Q3 2024

Nov 14, 2024
SELL
$7.86 - $9.7 $22,927 - $28,294
-2,917 Reduced 70.24%
1,236 $10,000
Q2 2024

Aug 13, 2024
BUY
$0.0 - $9.94 $0 - $29,750
2,993 Added 258.02%
4,153 $38,000
Q1 2024

May 13, 2024
BUY
$7.19 - $10.03 $8,340 - $11,634
1,160 New
1,160 $10,000
Q3 2023

Nov 09, 2023
SELL
$9.03 - $10.15 $20,904 - $23,497
-2,315 Reduced 94.53%
134 $1,000
Q2 2023

Aug 11, 2023
BUY
$9.51 - $13.03 $23,289 - $31,910
2,449 New
2,449 $23,000
Q3 2022

Nov 10, 2022
SELL
$12.1 - $14.23 $1,258 - $1,479
-104 Reduced 11.18%
826 $11,000
Q2 2022

Aug 10, 2022
BUY
$10.62 - $13.21 $796 - $990
75 Added 8.77%
930 $12,000
Q1 2022

May 16, 2022
BUY
$10.51 - $11.52 $2,186 - $2,396
208 Added 32.15%
855 $9,000
Q4 2021

Feb 14, 2022
BUY
$10.59 - $11.5 $4,553 - $4,945
430 Added 198.16%
647 $7,000
Q3 2021

Nov 15, 2021
SELL
$8.77 - $12.05 $6,279 - $8,627
-716 Reduced 76.74%
217 $3,000
Q2 2021

Aug 13, 2021
BUY
$8.9 - $14.15 $4,441 - $7,060
499 Added 114.98%
933 $10,000
Q1 2021

May 12, 2021
SELL
$11.02 - $13.86 $9,653 - $12,141
-876 Reduced 66.87%
434 $5,000
Q4 2020

Feb 11, 2021
BUY
$12.15 - $15.77 $6,791 - $8,815
559 Added 74.43%
1,310 $16,000
Q3 2020

Nov 12, 2020
BUY
$14.66 - $23.78 $11,009 - $17,858
751 New
751 $12,000
Q1 2020

May 01, 2020
SELL
$8.6 - $14.25 $9,933 - $16,458
-1,155 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$8.94 - $9.93 $10,325 - $11,469
1,155 New
1,155 $11,000
Q2 2019

Aug 14, 2019
SELL
$7.5 - $11.61 $10,275 - $15,905
-1,370 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$9.11 - $19.52 $12,480 - $26,742
1,370 New
1,370 $15,000
Q4 2018

Feb 14, 2019
SELL
$4.7 - $9.55 $13,667 - $27,771
-2,908 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$4.3 - $6.64 $3,822 - $5,902
889 Added 44.03%
2,908 $15,000
Q2 2018

Aug 14, 2018
BUY
$6.12 - $9.82 $10,563 - $16,949
1,726 Added 589.08%
2,019 $13,000
Q1 2018

May 15, 2018
SELL
$3.52 - $13.89 $8,000 - $31,571
-2,273 Reduced 88.58%
293 $3,000
Q4 2017

Feb 14, 2018
SELL
$4.05 - $5.5 $20 - $27
-5 Reduced 0.19%
2,566 $12,000
Q3 2017

Nov 14, 2017
BUY
$5.06 - $6.2 $13,009 - $15,940
2,571
2,571 $13,000

Others Institutions Holding DXR

# of Institutions
8
Shares Held
99.7K
Call Options Held
0
Put Options Held
0
View Full List

About DAXOR CORP

DXR Quotes by TradingView
  • Ticker DXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 4,041,670
  • Market Cap $54.4M
  • Description
  • Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...
More about DXR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email